Antipsychotic drugmakers target marketing dollars at DC Medicaid psychiatrists
The D.C. Department of Health (DOH) has released a study by George Washington University School of Public Health & Health Services (SPHHS) indicating the high levels of marketing by antipsychotic drug manufacturers to Medicaid ...
Sep 27, 2012
0
0